Influence Mechanism and Empirical Study of How National Centralized Drug Procurement Incentivizes Innovation Input in Listed Pharmaceutical Enterprises
王莹莹, 魏鸿吉
China Health Insurance . 2026, (6): 44 -54 .  DOI: 10.19546/j.issn.1674-3830.2026.6.005

Copyright © China Health Insurance, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.